SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer informs about business updates

22 Mar 2016 Evaluate

With reference to the earlier letter dated March 14, 2016 regarding Interim Injunction on the prohibition of manufacture and sale of ‘Corex’, Pfizer has now informed that the Honourable Delhi High Court at the hearing held on March 21, 2016, was pleased to extend the interim injunction suspending the operation of the Notification dated March 10, 2016, banning the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup till the next date of hearing. The Company is awaiting the Order from the Honourable Delhi High Court in this respect.

The above information is a part of company’s filings submitted to BSE.

Pfizer Share Price

4954.05 84.80 (1.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×